Literature DB >> 30107562

Breed-specific differences in the immune response to lipopolysaccharide in ewes.

Jessalyn M Hadfield1, Elizabeth C Bowdridge1, Ida Holásková2, Ted H Elsasser3, Robert A Dailey1.   

Abstract

Innate immune response to a lipopolysaccharide (LPS) challenge varies among sheep breeds. How different breeds respond to bacterial infections impacts management practices of sheep producers. Hence, clinical response, acute-phase response, and gene expression of pro- and anti-inflammatory markers in peripheral white blood cells (WBCs) were examined after an LPS challenge in Dorset and Suffolk ewes. Ewes received either PBS or 2.5 µg/kg LPS (i.v.) 4 to 5 d after onset of synchronized estrus. Blood was collected via jugular venipuncture intermittently for 24 h to determine WBC counts. Rectal temperatures and observations of behavioral/physical appearances were recorded hourly. After LPS, WBCs decreased the first hour (P = 0.0001) and rectal temperatures (P < 0.0001) increased through 4 h; both returned toward normal 6 h after challenge. Suffolk ewes exhibited greater changes in temperature (P = 0.03) and behavioral/physical responses (P < 0.0001) than Dorset ewes and had an enhanced acute-phase response demonstrated by increased concentrations of plasma haptoglobin (P = 0.04), as well as cortisol concentrations (P = 0.03). Real-time PCR was completed on buffy coat homogenates for expression of pro-inflammatory [CXCL8, IL-6, interferon gamma (IFNG), complement component 3 (C3), toll-like receptor 4 (TLR4), prostaglandin synthase 2 (PTGS2)] and anti-inflammatory [IL-10, superoxide dismutase 2 (SOD2), forkhead box P3 (FOXP3), peroxisome proliferator-activated receptor gamma (PPARG), mannose receptor C type 1 (MRC1), transforming growth factor β (TGFβ)] genes. After LPS treatment, gene expressions increased for CXCL8 (P = 0.0003), TLR4 (P = 0.004), SOD2 (P < 0.0001), and C3 (P = 0.003), while PPARG (P = 0.006) and MRC1 (P = 0.003) decreased. Overall, Dorset ewes had greater expression of TLR4 (P = 0.003), IL-10 (P = 0.045), PPARG (P = 0.002), FOXP3 (P = 0.001), and SOD2 (P = 0.0002), whereas Suffolk ewes had greater expression of IL-6 (P = 0.0007), IFNG (P = 0.02), PTGS2 (P = 0.0002), and C3 (P = 0.008). Suffolk ewes also displayed greater expression of IL-6 (P = 0.002) and C3 (P = 0.0004) in response to LPS. In conclusion, differences in gene expression may explain the enhanced inflammatory response in Suffolk ewes and may predispose Suffolk ewes to be more responsive to bacterial infection than Dorset ewes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30107562      PMCID: PMC6162594          DOI: 10.1093/jas/sky288

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Patterns of late embryonic and fetal mortality and association with several factors in sheep.

Authors:  A B Dixon; M Knights; J L Winkler; D J Marsh; J L Pate; M E Wilson; R A Dailey; G Seidel; E K Inskeep
Journal:  J Anim Sci       Date:  2007-01-15       Impact factor: 3.159

3.  Radioimmunoassay for bovine tumor necrosis factor: concentrations and circulating molecular forms in bovine plasma.

Authors:  D C Kenison; T H Elsasser; R Fayer
Journal:  J Immunoassay       Date:  1990

Review 4.  Circulating cytokines as mediators of fever.

Authors:  M G Netea; B J Kullberg; J W Van der Meer
Journal:  Clin Infect Dis       Date:  2000-10       Impact factor: 9.079

5.  St. Croix sheep produce a rapid and greater cellular immune response contributing to reduced establishment of Haemonchus contortus.

Authors:  Scott A Bowdridge; Anne M Zajac; David R Notter
Journal:  Vet Parasitol       Date:  2015-02-04       Impact factor: 2.738

Review 6.  Alternative activation of macrophages: mechanism and functions.

Authors:  Siamon Gordon; Fernando O Martinez
Journal:  Immunity       Date:  2010-05-28       Impact factor: 31.745

7.  Bacterial lipopolysaccharide induces an endocrine switch from prostaglandin F2alpha to prostaglandin E2 in bovine endometrium.

Authors:  Shan Herath; Sonia T Lilly; Deborah P Fischer; Erin J Williams; Hilary Dobson; Clare E Bryant; I Martin Sheldon
Journal:  Endocrinology       Date:  2008-12-04       Impact factor: 4.736

Review 8.  Seminal fluid and the generation of regulatory T cells for embryo implantation.

Authors:  Sarah A Robertson; Jelmer R Prins; David J Sharkey; Lachlan M Moldenhauer
Journal:  Am J Reprod Immunol       Date:  2013-04       Impact factor: 3.886

Review 9.  The many faces of PPARgamma: anti-inflammatory by any means?

Authors:  Attila Szanto; Laszlo Nagy
Journal:  Immunobiology       Date:  2008-09-02       Impact factor: 3.144

10.  Mechanisms underlying growth hormone effects in augmenting nitric oxide production and protein tyrosine nitration during endotoxin challenge.

Authors:  Ted H Elsasser; Stanislaw Kahl; Carol MacLeod; Benjamin Nicholson; James L Sartin; Congjun Li
Journal:  Endocrinology       Date:  2004-03-24       Impact factor: 4.736

View more
  3 in total

1.  Identification of Ovine Serum miRNAs Following Bacterial Lipopolysaccharide Challenge.

Authors:  Ankita Sharma; Umesh K Shandilya; Tianna Sullivan; Danielle Naylor; Angela Canovas; Bonnie A Mallard; Niel A Karrow
Journal:  Int J Mol Sci       Date:  2020-10-25       Impact factor: 5.923

2.  Effect of LPS and LTA stimulation on the expression of TLR-pathway genes in PBMCs of Akkaraman lambs in vivo.

Authors:  Esma Gamze Aksel; Bilal Akyüz
Journal:  Trop Anim Health Prod       Date:  2021-01-03       Impact factor: 1.559

3.  Effects of Dietary Resveratrol Supplementation on Growth Performance and Anti-Inflammatory Ability in Ducks (Anas platyrhynchos) through the Nrf2/HO-1 and TLR4/NF-κB Signaling Pathways.

Authors:  Hao Yang; Yingjie Wang; Mengru Liu; Xiao Liu; Yihan Jiao; Sanjun Jin; Anshan Shan; Xingjun Feng
Journal:  Animals (Basel)       Date:  2021-12-18       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.